Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ZVRA | WVE |
|---|---|---|
| Price | $11.08 | $3.54 |
| Change today | ▲ 3.26% | ▲ 0.57% |
| Market cap | $657.97M | $697.55M |
| Return, 3 months | -20.5% | -43.9% |
| Return, year to date | +23.7% | -79.2% |
| Return, 1 year | +4.1% | -51.8% |
| P/E (TTM) | 11.9 | -3.3 |
| P/B | 3.0 | 1.5 |
| P/E percentile vs own 5y | 85th | 64th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +53.3% | -73.9% |
| Net profit growth (YoY) | -88.3% | -37.4% |
| Gross margin | 95.5% | – |
| Operating margin | 28.7% | -333.4% |
| Net margin | 42.8% | -309.7% |
| Return on equity | 34.8% | -68.3% |
| Analyst target vs. price | +127.9% | +416.1% |
| Analyst buy share | 100% | 92% |
| RSI (14) | 47 | 27 |
| 30-day volatility | 43.9% | 44.9% |
| Max drawdown, 1 year | -35.5% | -83.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
